193 related articles for article (PubMed ID: 23512965)
1. Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression.
Brown MV; Compton SA; Milburn MV; Lawton KA; Cheatham B
Obesity (Silver Spring); 2013 Dec; 21(12):E561-70. PubMed ID: 23512965
[TBL] [Abstract][Full Text] [Related]
2. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
Patterson RE; Kalavalapalli S; Williams CM; Nautiyal M; Mathew JT; Martinez J; Reinhard MK; McDougall DJ; Rocca JR; Yost RA; Cusi K; Garrett TJ; Sunny NE
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E484-94. PubMed ID: 26814015
[TBL] [Abstract][Full Text] [Related]
3. Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress.
Yuzefovych L; Wilson G; Rachek L
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1096-105. PubMed ID: 20876761
[TBL] [Abstract][Full Text] [Related]
4. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
5. A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
[TBL] [Abstract][Full Text] [Related]
6. Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells.
Hetherington AM; Sawyez CG; Zilberman E; Stoianov AM; Robson DL; Borradaile NM
Cell Physiol Biochem; 2016; 39(4):1648-62. PubMed ID: 27626926
[TBL] [Abstract][Full Text] [Related]
7. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.
Gorden DL; Ivanova PT; Myers DS; McIntyre JO; VanSaun MN; Wright JK; Matrisian LM; Brown HA
PLoS One; 2011; 6(8):e22775. PubMed ID: 21857953
[TBL] [Abstract][Full Text] [Related]
8. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes.
Mei S; Ni HM; Manley S; Bockus A; Kassel KM; Luyendyk JP; Copple BL; Ding WX
J Pharmacol Exp Ther; 2011 Nov; 339(2):487-98. PubMed ID: 21856859
[TBL] [Abstract][Full Text] [Related]
10. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes.
Schultz Moreira AR; Rüschenbaum S; Schefczyk S; Hendgen-Cotta U; Rassaf T; Broering R; Hardtke-Wolenski M; Buitrago-Molina LE
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167328
[TBL] [Abstract][Full Text] [Related]
11. [The unity of pathogenesis of insulin resistance syndrome and non-alcoholic fatty disease of liver. The metabolic disorder of fatty acids and triglycerides].
Titov VN; Ivanova KV; Malyshev PP; Kaba SI; Shiriaeva IuK
Klin Lab Diagn; 2012 Nov; (11):3-12. PubMed ID: 23305008
[TBL] [Abstract][Full Text] [Related]
12. Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes.
Capel F; Cheraiti N; Acquaviva C; Hénique C; Bertrand-Michel J; Vianey-Saban C; Prip-Buus C; Morio B
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2000-2010. PubMed ID: 27725263
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum.
Aggarwal S; Yadav V; Maiwall R; Rastogi A; Pamecha V; Bedi O; Maras JS; Trehanpati N; Ramakrishna G
Biochem Biophys Res Commun; 2023 Feb; 643():129-138. PubMed ID: 36603530
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of the Y220C mutant p53 against steatosis: good news?
Gori M; Barbaro B; Arciello M; Maggio R; Viscomi C; Longo A; Balsano C
J Cell Physiol; 2014 Sep; 229(9):1182-92. PubMed ID: 24395441
[TBL] [Abstract][Full Text] [Related]
16. Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells.
Kwon B; Lee HK; Querfurth HW
Biochim Biophys Acta; 2014 Jul; 1843(7):1402-13. PubMed ID: 24732014
[TBL] [Abstract][Full Text] [Related]
17. Cellular glutathione in fatty liver in vitro models.
Garcia MC; Amankwa-Sakyi M; Flynn TJ
Toxicol In Vitro; 2011 Oct; 25(7):1501-6. PubMed ID: 21620948
[TBL] [Abstract][Full Text] [Related]
18. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
Chavez-Tapia NC; Rosso N; Tiribelli C
BMC Gastroenterol; 2012 Mar; 12():20. PubMed ID: 22380754
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.
Leamy AK; Egnatchik RA; Young JD
Prog Lipid Res; 2013 Jan; 52(1):165-74. PubMed ID: 23178552
[TBL] [Abstract][Full Text] [Related]
20. In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis.
García-Ruiz I; Solís-Muñoz P; Fernández-Moreira D; Muñoz-Yagüe T; Solís-Herruzo JA
Dis Model Mech; 2015 Feb; 8(2):183-91. PubMed ID: 25540128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
